Investor News
Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film
Indivior Is Granted Preliminary Injunction on Generic (buprenorphine and naloxone) Sublingual Film Slough, UK, 13 July…
Read moreIndivior Sees FY 2018 Net Revenue and Adjusted Net Income Below Previous Expectations
Slough, UK, 11 July 2018 – Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced…
Read moreIndivior to Announce and Present Half Year 2018 Results on July 25th
Slough, UK, and Richmond, VA, 10 July 2018 – Indivior PLC (LON: INDV) today announced…
Read moreH1 2018 Financial Results Presentation (July 25th)
Listen to the live webcast here.
Read moreIndivior’s Temporary Restraining Order is Extended
Indivior’s Temporary Restraining Order is Extended Slough, UK, 28 June 2018 – Indivior PLC (LON: INDV)…
Read moreIndivior Is Granted Temporary Restraining Order
Indivior Is Granted Temporary Restraining Order Slough, UK, 15 June 2018 – Indivior PLC (LON:…
Read moreIndivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy’s Launch “At-Risk”
Slough, UK, 15 June 2018 – Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced…
Read moreIndivior Receives Subpoena from California Department of Insurance
Slough, UK and Richmond, VA, May 31, 2018 – Indivior PLC (LON: INDV) announced today…
Read moreIndivior Announces Regulatory Submission to Australia’s Therapeutic Goods Administration (TGA) for SUBLOCADE™ (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Slough, UK and Richmond, VA, 25 May 2018 – Indivior PLC (LON: INDV) today announced…
Read moreWebcast Event: Jefferies 2018 Global Healthcare Conference, June 5th at 8:30 a.m. New York City time
Webcast available here.
Read more